
|Articles|March 1, 1999
The American Journal of Managed Care
- March 1999
- Volume 5
- Issue 3
Incorporating Clinical Outcomes and Economic Consequences into Drug Formulary Decisions: A Practical Approach
Advertisement
Articles in this issue
over 26 years ago
Economic Impact of Delaying or Preventing AIDS in Persons with HIVover 26 years ago
Erectile Dysfunction: The Primary Care Practitioner's Viewover 26 years ago
Drug-Nutrient InteractionsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms
3
Cohere Health Findings on AI in Prior Authorization Conflict With AMA Data
4
Contributor: Why Public Health Keeps Failing—and How to Fix It
5